Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -133.11x is 83% below its 3-year average of -72.57x, near the high end of its 3-year range (-29333.00x–-4.11x).
97.82% above its 12-month average of -6114.23x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): -29333.00x.
INTEREST COVERAGE RATIO
-133.11x
INTEREST COVERAGE RATIO AVG TTM
-6114.23x
INTEREST COVERAGE RATIO AVG 3Y
-77.84x
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+97.82%
CURRENT VS 3Y AVG
-71.00%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-4.07x
median of 335 covered companies
CURRENT VS SECTOR MEDIAN
-3170.52%
vs the sector median at left
BioAge Labs Inc.
Market Cap
$241.18M
Interest Coverage Ratio
-133.11x
TTM Avg
-6114.23x
3Y Avg
-77.84x
5Y Avg
N/A
Market Cap
$239.39M
Interest Coverage Ratio
0.97x
TTM Avg
0.97x
3Y Avg
0.97x
5Y Avg
0.97x
Market Cap
$240.76M
Interest Coverage Ratio
-1.08x
TTM Avg
0.39x
3Y Avg
0.39x
5Y Avg
0.20x
Market Cap
$244.19M
Interest Coverage Ratio
0.57x
TTM Avg
0.57x
3Y Avg
0.57x
5Y Avg
0.57x
Market Cap
$240.55M
Interest Coverage Ratio
-3.60x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$246.96M
Interest Coverage Ratio
-2.74x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$248.92M
Interest Coverage Ratio
-1280.37x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$249.82M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| BioAge Labs Inc. (BIOA) | $241.18M | -133.11x | -6114.23x | -77.84x | N/A |
| Akebia Therapeutics, Inc. (AKBA)vs › | $239.39M | 0.97x | 0.97x | 0.97x | 0.97x |
| High Tide Inc. (HITI)vs › | $240.76M | -1.08x | 0.39x | 0.39x | 0.20x |
| Lifecore Biomedical, Inc. (LFCR)vs › | $244.19M | 0.57x | 0.57x | 0.57x | 0.57x |
| Biodesix, Inc. (BDSX)vs › | $240.55M | -3.60x | N/A | N/A | N/A |
| Galectin Therapeutics Inc. (GALT)vs › | $246.96M | -2.74x | N/A | N/A | N/A |
| InflaRx N.V. (IFRX)vs › | $248.92M | -1280.37x | N/A | N/A | N/A |
| Greenwich LifeSciences, Inc. (GLSI)vs › | $249.82M | N/A | N/A | N/A | N/A |
| Invivyd, Inc. (IVVD)vs › | $251.06M | N/A | N/A | N/A | N/A |
| CAMP4 Therapeutics Corporation (CAMP)vs › | $252.90M | N/A | 0.97x | 1.45x | 67.07x |
Interest Coverage
-133.1x
Debt/Equity
0.01
Current Ratio
17.19
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | -29333.00x |
| 2026-03-31 | -650.64x |
| 2025-12-31 | -308.95x |
| 2025-09-30 | -155.30x |
| 2025-06-30 | -123.24x |
| 2025-03-31 | -64.49x |
| 2024-12-31 | -79.50x |
| 2024-09-30 | -63.79x |
| 2024-06-30 | -34.47x |
| 2024-03-31 | -10.53x |
| 2023-12-31 | -5.31x |
| 2023-09-30 | -4.11x |
| 2023-06-30 | -6.58x |
| 2023-03-31 | -14.51x |
